Name

CAS Star

Legal name

中科创星科技投资有限公司

Website

http://www.casstar.com.cn

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Venture Capital / Private Equity

NAICS

Portfolio Management and Investment Advice (523940), Other Financial Investment Activities (5239), Funds, Trusts, and Other Financial Vehicles (525)

SIC

Investment Advice (6282)

akta.pro primary industry

Early-Stage Venture Capital (Series A/B) (FSANAAAB)

akta.pro secondary industries

Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD), Late-Stage Venture Capital (Series C+) (FSANAAAC)

Keywords

• Venture capital investing
• Hard technology investment
• Technology startup incubation
• Early stage equity funding
• Technology commercialization

Headquarters

HQ city

Xian

HQ country

China

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Venture Capital Fund Management: CAS Star manages multiple venture capital funds including Xike Angel Fund, Qin Chuangyuan Hard Tech Fund, Shaanxi Optoelectronic Integration Fund, Beijing Hard Tech VC Fund, and others, with cumulative scale exceeding 180 billion yuan. Revenue is generated through management fees and carried interest (performance fees) from portfolio company exits.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

CAS Star is an early-stage venture capital firm dedicated exclusively to hard technology (硬科技) investments, deploying capital from multiple specialized funds into pre-seed, seed, and Series A startups across eight technology verticals. The firm operates a 'research institution + early investment + entrepreneurship platform + post-investment services' ecosystem, providing investment, incubation, and financing solutions to technology entrepreneurs through direct equity investment, structured accelerator programs, scientific exchange platforms, and shared R&D infrastructure.

Product overview

CAS Star is a venture capital firm specializing in early-stage hard technology investments, operating as a comprehensive ecosystem that combines research institution partnerships, early-stage investment funds, startup incubation platforms, and post-investment services. The firm manages multiple specialized funds including the Xike Angel Fund, Qin Chuangyuan Hard Technology Fund, Shaanxi Photonic Integration Fund, and Beijing Hard Technology VC Fund with combined scale exceeding 18 billion RMB. The investment portfolio spans eight core technology sectors: optoelectronic chips, artificial intelligence, biotechnology, aerospace, intelligent manufacturing, information technology, new energy, and new materials. CAS Star supports portfolio companies through the Hard Technology Champion Entrepreneurship Camp (硬科技冠军营), the Good Hope Science Salon (好望角科学沙龙) scientific exchange platform, and co-founded the Photonic Academy (光电子先导院) shared technology service platform. The firm operates from three headquarters in Xi'an, Beijing, and Shanghai, with Shanghai focusing on frontier industries and original innovation through 'advanced incubation' from principle and paper stages.

Differentiator

Problem solved

Functional benefit

Brands

• 硬科技冠军营: Hard Technology Champion Camp - an entrepreneurship training program for hard tech startups
• 好望角科学沙龙
• 西科天使基金
• 秦创原硬科技基金
• 陕西光电子集成基金
• 北京硬科技创投基金

Products and services

• Xike Angel Fund (西科天使基金)
• Qin Chuangyuan Hard Technology Fund (秦创原硬科技基金)
• Shaanxi Optoelectronic Integration Fund (陕西光电子集成基金)
• Beijing Hard Technology Venture Capital Fund (北京硬科技创投基金)
• Hard Technology Champion Entrepreneurship Camp (硬科技冠军营)
• Cape of Good Hope Science Salon (好望角科学沙龙)
• Photonic Academy (光电子先导院)

Quantifiable outcome

• 600+ invested companies with combined portfolio market value exceeding 16,000 billion yuan
• +2 more outcomes

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Takeda (武田制药)minorStrategic or Co-development Partner · 14 May 2026Degron Therapeutics, a CAS Star portfolio company, maintains partnerships with pharmaceutical companies including Takeda, focused on molecular glue-based targeted protein degradation drug discovery.

Scale indicators5 records

Recent moves9 records

Expansion highlights5 records

Broad incumbents

• Hillhouse Capital (高瓴资本): Mega-asset manager with broad private and public exposure to Chinese technology. While not a pure early-stage hard-tech specialist, it increasingly competes with CAS Star for the same hard-tech deals at scale.

Direct peers

• Yunfeng Capital (云锋基金): Tech-led growth investor with deep industrial LP relationships and significant hard-tech/AI exposure. Comparable to CAS Star as a Chinese VC platform competing for tech founder share.
• Source Code Capital (源码资本): Top-tier Chinese early-stage VC focused on technology and digital economy. Compares to CAS Star in fund stage, sector breadth across frontier tech, and similar LP profile.
• MatrixPartners China (经纬创投): Leading early-stage VC in China focused on technology, consumer and healthcare. Competes with CAS Star for high-quality early-stage tech founders and shares the early-stage institutional LP profile.
• IDG Capital: Pioneer early-stage technology VC in China with broad sector coverage including semiconductors, AI and biotech. Overlaps directly with CAS Star in hard-tech investing and competes for similar seed-to-Series A hard-tech deals.
• Fortune Venture Capital (达晨财智): One of China's largest domestic VCs with a long track record in hard-tech and intelligent manufacturing investments. Comparable in size, LP base, and focus on industrial-tech exits.
• Lenovo Capital and Incubator Group (联想之星): CVC-backed early-stage investor and incubator focused on AI, semiconductors, robotics and biotech. Most directly comparable to CAS Star given its corporate-affiliated incubation model and hard-tech thesis.
• Northern Light Venture Capital (北极光创源): Early-to-growth stage VC investing in TMT, clean tech, healthcare and advanced manufacturing. Comparable to CAS Star in the hard-tech seed-to-Series B sweet spot and in LP composition.
• Sequoia Capital China (红杉中国): One of China's most prominent venture capital firms with deep exposure to early-stage technology investing. Directly comparable to CAS Star in targeting hard-tech and frontier-tech startups, and competes for the same founder and LP mindshare.

Others

• Zero2IPO Group (清科集团): China's leading VC/PE research, data and fundraising-services platform. Comparable to CAS Star as an ecosystem participant — Zero2IPO ranks CAS Star as China's No.1 early-stage VC, and both anchor the institutional VC information ecosystem in China.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments311 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CAS Star